Prophylactic treatment with plasma-derived C1 inhibitor in idiopathic non-histaminergic angioedema

Pediatr Allergy Immunol. 2016 Sep;27(6):658-9. doi: 10.1111/pai.12592. Epub 2016 Jun 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angioedema / drug therapy*
  • Child
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Humans
  • Male
  • Off-Label Use
  • Severity of Illness Index

Substances

  • Complement C1 Inhibitor Protein
  • SERPING1 protein, human